Skip to main content
Clinical Trials/NCT02213471
NCT02213471
Completed
Not Applicable

Patient Preference for Biopsy Notification

Maria Wei1 site in 1 country301 target enrollmentJuly 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Elevated Risk for Melanoma
Sponsor
Maria Wei
Enrollment
301
Locations
1
Primary Endpoint
Patient preference for biopsy notification
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Effective communication between physician and patient is fundamental to effective care. The recent introduction of electronic patient on-line portals has the potential to change the communication landscape. The investigators surveyed patients to assess their preferred modality for biopsy notification at 3 institutions with differing patient access to on-line portals, to ascertain what patient preferences are currently and if it has changed from historical preferences. Our hypothesis is that as patients become more familiar with ln-line portals, their preferences will likely reflect familiarity with this modality.

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
July 2013
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Maria Wei
Responsible Party
Sponsor Investigator
Principal Investigator

Maria Wei

Associate Professor of Dermatology

University of California, San Francisco

Eligibility Criteria

Inclusion Criteria

  • Patients who were 18 years of age or older and English speaking were eligible to participate

Exclusion Criteria

  • Younger than 18, non-English speaking.

Outcomes

Primary Outcomes

Patient preference for biopsy notification

Time Frame: 1 year

Patients were asked to rank in order of preference their preferred method for being notified of a skin biopsy result

Study Sites (1)

Loading locations...

Similar Trials